REGENXBIO Inc (RGNX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -31.954 | -39.401 | 26.919 | -18.188 | -18.448 | 14.032 | -28.793 | -37.448 |
Return on Equity (%) | -33.268 | -42.446 | 28.889 | -19.756 | -26.874 | 22.388 | -43.783 | -63.651 |
Return on Invested Capital (%) | -63.171 | -58.82 | 33.426 | -42.996 | -35.466 | 42.534 | -78.753 | -93.854 |
Operating Margin (%) | -1381.608 | -704.022 | 47.649 | -276.695 | -68.086 | 35.617 | -228.124 | -284.55 |
Net Profit Margin (%) | -1372.129 | -704.022 | 45.737 | -268.876 | -71.975 | 27.18 | -248.679 | -291.986 |
Book Value Per Share | 6.109 | 5.849 | 14.088 | 12.17 | 10.08 | 17.845 | 11.922 | 7.086 |
Earnings Per Share | -2.378 | -2.338 | 2.767 | -2.561 | -2.969 | 2.985 | -6.474 | -5.99 |
Cash Per Share | 0.938 | 1.491 | 2.092 | 1.879 | 9.03 | 8.06 | 2.239 | 0.785 |
Working Capital Per Share | 3.161 | 4.907 | 8.741 | 8.417 | 12.001 | 9.067 | 6.595 | 4.653 |
Operating Profit Per Share | 0.158 | 0.277 | 5.783 | 0.73 | 3.396 | 9.995 | 1.796 | 1.599 |
EBIT Per Share | -2.395 | -2.338 | 2.883 | -2.635 | -2.829 | 3.298 | -6.476 | -5.993 |
EBITDA Per Share | -2.395 | -2.338 | 2.883 | -2.635 | -2.829 | 3.298 | -6.476 | -5.993 |
Free Cash Flow Per Share | -2.091 | -2.195 | 3.024 | -2.437 | -2.476 | 4.727 | -6.062 | -6.157 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 26,48M | 31,3M | 36,12M | 36,99M | 37,48M | 42,83M | 43,3M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 43,3M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -334 | N/A | N/A | N/A | -392.76 | N/A | N/A |
Net Profit Margin (%) | N/A | -348.396 | N/A | N/A | N/A | -405.39 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 389,42M |
Ratio cours/bénéfice | -1,46 |
Ratio prix/ventes | 4,27 |
Ratio prix/liquidités | 11,17 |
Ratio prix/valeur comptable | 1,24 |
Rendement de dividende | - |
Actions en circulation | 49,55M |
Volume moyen (1 semaine) | 1,52M |
Volume moyen (1 mois) | 2M |
Variation sur 52 semaines | -57,73% |
Plus haut sur 52 semaines | 28,80 |
Plus bas sur 52 semaines | 7,14 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales